Please login to the form below

Not currently logged in
Email:
Password:

Tudor Reilly opens new London office

Tudor Reilly has announced the opening of a second office in Baker Street, London, to be led by associate director Nicole Yost

Tudor Reilly has announced the opening of a second office in Baker Street, London, to be led by associate director Nicole Yost.

The healthcare communications consultancy, which is just two years old, has seen a period of sustained growth during 2009 and aims to continue to expand the team during 2010.

Tudor Reilly's managing director, Julie Walters, said: "The opening of a second office has come earlier than expected. We have doubled in size over the past 12 months and the London office is an exciting step for Tudor Reilly. The central location in London will enable us to attract more new talent to build a strong team and continue to meet the wide-ranging needs of our clients."

Tudor Reilly is a corporate communications agency focused on healthcare. It combines in-depth media knowledge with a solid understanding of science and the pharmaceutical industry to provide strategic counsel, high-level coaching and rigorous implementation.

14th January 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

What does HCP engagement look like in a post-Covid world?
HCP engagement has changed as a result of the Covid-19 pandemic, with pharmaceutical companies and agencies having to rapidly adjust to a new way of communicating. Digital channels have become...
Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...